Target intelligence / Profile preview

Xenobiotic metabolism system

Molecular classification
Enzyme, Transporter, Nuclear receptor
01

Overview

The term "Detoxify" refers to the biological process of xenobiotic metabolism, a critical physiological system primarily centered in the liver that neutralizes and eliminates foreign chemicals (xenobiotics) and endogenous waste products. This system is organized into three distinct phases: Phase I involves modification (typically oxidation) by enzymes such as the Cytochrome P450 (CYP) family; Phase II involves conjugation of these intermediates to polar molecules via enzymes like Glutathione S-transferases (GST) and UDP-glucuronosyltransferases (UGT); and Phase III involves the active transport of these water-soluble products out of the cell for excretion via ABC transporters like P-glycoprotein. The system is regulated by master xenosensors, including the Pregnane X receptor (PXR) and the Constitutive Androstane receptor (CAR), which induce enzyme expression in response to toxicant exposure. While the process itself is not a single molecular target, its constituent enzymes and regulatory receptors are frequently targeted in pharmacology to manage drug-drug interactions, treat acute poisoning, or address chemoresistance in oncology.

Other names
Xenobiotic metabolismPhase I/II/III metabolismMetabolic detoxificationDrug metabolism systemBiotransformation system
02

Mechanism of action

Drugs interact with this system by serving as ligands for nuclear receptors (e.g., PXR, CAR, Nrf2) to induce the expression of metabolic enzymes and transporters, or by directly inhibiting specific enzymes (e.g., CYP3A4) to alter the clearance and therapeutic window of co-administered medications.

03

Biological functions

MetabolismHomeostasisExcretionAntioxidant responseSignal transduction
04

Disease associations

CancerDrug-induced liver injury (DILI)PoisoningMetabolic disorderNeurodegenerative disease
05

Safety considerations

Drug-drug interactions (DDI)Activation of pro-carcinogensChemoresistance in cancer cellsHepatotoxicity
06

Interacting drugs

Rifampicin

5 more in the full profile.

07

Biomarkers

Alanine aminotransferase (ALT)Aspartate aminotransferase (AST)Gamma-glutamyl transferase (GGT)BilirubinGlutathione (GSH) levels

Beyond the preview

Go deeper on Xenobiotic metabolism system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xenobiotic metabolism system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call